Trials / Completed
CompletedNCT06213805
Efficacy and Safety of Minimally Invasive Micro-Sclerostomy (MIMS) in Glaucoma Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Hôpital Privé de la Baie · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objective is to evaluate the effectiveness of MIMS in patients with an indication for glaucoma surgery, compared to traditional surgery. The secondary objective is to assess safety. The investigating ophthalmologist will follow the patients and collect clinical data in order to identify the benefits and complications of MIMS. Patients are expected to experience fewer complications compared to traditional glaucoma surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Minimally invasive microsclerostomy | MIMS is a filtering glaucoma surgery, which consists of creating a sclero-corneal drainage channel, to allow the flow of aqueous humor and therefore the reduction of intraocular pressure. This surgery is extremely quick, lasting 3 to 5 minutes, according to recent MIMS studies, in contrast to the duration of a trabeculectomy, the classic glaucoma surgery, which varies between 20 and 60 minutes. |
Timeline
- Start date
- 2024-01-15
- Primary completion
- 2026-03-26
- Completion
- 2026-03-26
- First posted
- 2024-01-19
- Last updated
- 2026-04-01
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT06213805. Inclusion in this directory is not an endorsement.